Hybrid Positron Emission Tomography and Magnetic Resonance Imaging Guided Microsurgical Management of Glial Tumors: Case Series and Review of the Literature
- PMID: 39061688
- PMCID: PMC11275485
- DOI: 10.3390/diagnostics14141551
Hybrid Positron Emission Tomography and Magnetic Resonance Imaging Guided Microsurgical Management of Glial Tumors: Case Series and Review of the Literature
Abstract
In this case series, we aimed to report our clinical experience with hybrid positron emission tomography (PET) and magnetic resonance imaging (MRI) navigation in the management of recurrent glial brain tumors. Consecutive recurrent neuroglial brain tumor patients who underwent PET/MRI at preoperative or intraoperative periods were included, whereas patients with non-glial intracranial tumors including metastasis, lymphoma and meningioma were excluded from the study. A total of eight patients (mean age 50.1 ± 11.0 years) with suspicion of recurrent glioma tumor were evaluated. Gross total tumor resection of the PET/MRI-positive area was achieved in seven patients, whereas one patient was diagnosed with radiation necrosis, and surgery was avoided. All patients survived at 1-year follow-up. Five (71.4%) of the recurrent patients remained free of recurrence for the entire follow-up period. Two patients with glioblastoma had tumor recurrence at the postoperative sixth and eighth months. According to our results, hybrid PET/MRI provides reliable and accurate information to distinguish recurrent glial tumor from radiation necrosis. With the help of this differential diagnosis, hybrid imaging may provide the gross total resection of recurrent tumors without harming eloquent brain areas.
Keywords: hybrid imaging; magnetic resonance imaging; positron emission tomography; radiation necrosis; recurrent glial tumor.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.Ann Nucl Med. 2004 Jun;18(4):291-6. doi: 10.1007/BF02984466. Ann Nucl Med. 2004. PMID: 15359921 Clinical Trial.
-
Recurrent high-grade glioma surgery: a multimodal intraoperative protocol to safely increase extent of tumor resection and analysis of its impact on patient outcome.Neurosurg Focus. 2021 Jan;50(1):E20. doi: 10.3171/2020.10.FOCUS20744. Neurosurg Focus. 2021. PMID: 33386001
-
Comparison of O-(2-18F-Fluoroethyl)-L-Tyrosine Positron Emission Tomography and Perfusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Patients with Progressive and Recurrent Glioma: A Hybrid Positron Emission Tomography/Magnetic Resonance Study.World Neurosurg. 2018 May;113:e727-e737. doi: 10.1016/j.wneu.2018.02.139. Epub 2018 Mar 3. World Neurosurg. 2018. PMID: 29510293
-
Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET)/Computed Tomography Features of Atypical Teratoid/Rhabdoid Tumors: Case Series and Review.J Child Neurol. 2022 Dec;37(12-14):1003-1009. doi: 10.1177/08830738221129968. J Child Neurol. 2022. PMID: 36417494 Review.
-
Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.Chin J Cancer. 2014 Jan;33(1):16-24. doi: 10.5732/cjc.013.10217. Chin J Cancer. 2014. PMID: 24384237 Free PMC article. Review.
Cited by
-
Multidimensional analysis reveals gene expression, cell interactions, and signaling networks in glioma and Alzheimer's disease.Discov Oncol. 2025 Feb 19;16(1):208. doi: 10.1007/s12672-025-01934-4. Discov Oncol. 2025. PMID: 39969703 Free PMC article.
References
-
- Lacroix M., Abi-Said D., Fourney D.R., Gokaslan Z.L., Shi W., DeMonte F., Lang F.F., McCutcheon I.E., Hassenbusch S.J., Holland E. A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J. Neurosurg. 2001;95:190–198. doi: 10.3171/jns.2001.95.2.0190. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources